Benjamin Hannan, director of reform and transformation at NHS Fife, has been honoured with the prestigious title of Fellow of the Royal Pharmaceutical Society
(RPS), marking a significant milestone in his career.
Hailing from Falkirk, Hannan is the youngest Scottish Fellow in the society's history, a testament to his exceptional contributions to the field of pharmacy.
The fellowship, a distinction bestowed upon members who have demonstrated remarkable achievements in advancing pharmaceutical knowledge or have shown exceptional
distinction in pharmacy science, practice, profession, or history, is a recognition of Hannan's dedication and expertise in the field.
Expressing his gratitude, Hannan told The Faulkner Herlad, "I am delighted and humbled to have been made a Fellow of the Royal Pharmaceutical Society."
The Association of the British Pharmaceutical Industry (ABPI) has issued a challenge to all political parties to outline detailed plans aimed at maximising
the industry's role in driving UK health and economic prosperity.
In 2022, the pharmaceutical sector invested £9 billion in UK research and development, generating £16.4 billion in economic value and sustaining 126,000 high-skilled
jobs nationwide.
Ahead of the 2024 general elections, ABPI's Manifesto for Investment, Health, and Growth outlines a strategic framework to enhance patient care within the NHS.
It includes expanding access to new medicines through clinical trials and bolstering domestic manufacturing capabilities.
It also includes creating additional high-skilled employment opportunities across the UK.
As per the association, the potential impact of these initiatives is substantial.
Explore the various causes of forehead pain, when to consult a healthcare professional, and the diagnostic methods used to identify the root cause of the pain.